thewayne: (Default)
[personal profile] thewayne
The drug, Aloquin, was used to treat eczema and consisted of an old generic antibiotic and extracts from aloe vera. The price went from about $250 a tube to almost $10,000 a tube. Apparently patients balked at the price and rejected the prescriptions.

Insurance plans wouldn't pay $10k for such an old medication of dubious efficacy, the company had trouble being profitable. The article states that "The filing also said that manufacturing issues, a dispute with a wholesaler, and competition from generic creams contributed to the bankruptcy."

https://arstechnica.com/science/2019/02/infamous-pharma-company-declares-bankruptcy-after-3900-price-hike/

For myself, in November I went and saw my lung doctor about a persistent cough that had been bugging me for some months. He changed one of my meds, an inhaler for asthma control (I also carry a rescue inhaler) to two nebulized meds. I had been getting the inhaler for free via mail order. The two nebulized meds were $6 each at my local pharmacy. Starting in January, one of the meds were removed from my pharmacy benefits company's formulary and replaced with a drug that became $140 at my local pharmacy - and would increase in price after 3 months!

So I was forced to get it mail order, the two drugs became $130 for a three month supply.

I don't like getting my meds mail order as by getting them locally, that money supports local jobs, not jobs in another state. We have a bad enough economy here, and it may not be much, but it's something.

Date: 2019-02-07 03:09 am (UTC)
dewline: Text - "On the DEWLine" (Default)
From: [personal profile] dewline
On the Ars Technica article: this is what companies get for overcharging worse than usurers out of Biblical legend. What such companies deserve.

As for the rest of it...seems like a hellish mess of a choice for a patient to have to make.

Date: 2019-02-10 05:37 am (UTC)
silveradept: A kodama with a trombone. The trombone is playing music, even though it is held in a rest position (Default)
From: [personal profile] silveradept
It turns out, then, there is a limit to greed in the pharmaceutical marketplace. Just not as low a ceiling as I would like.

January 2026

S M T W T F S
    1 23
45678910
11121314151617
18192021222324
25262728293031

Most Popular Tags

Style Credit

Expand Cut Tags

No cut tags
Page generated Jan. 3rd, 2026 03:23 am
Powered by Dreamwidth Studios